Gena Angelo

Gena Angelo is a seasoned professional in pharmacovigilance with extensive experience spanning over three decades. Currently serving as Director of QPPV Operations at Regeneron since January 2024, Gena previously held the position of Associate Director of Risk Management at the same company from October 2019 to June 2023. Prior experience includes key roles at Roche, such as Group Head of PV Processes and Senior Pharmacovigilance Analyst, where Gena managed critical pharmacovigilance processes and ensured compliance with regulatory standards. Earlier in Gena's career at GSK, significant contributions were made as Therapeutic Area Head for Safety Evaluation and Risk Management, overseeing the safety profiles of vaccines. Gena also held positions as an Expert Safety Scientist and Scientific Writer, contributing to clinical development research. Academic background includes a Bachelor of Science in Biology from Central Luzón State University in the Philippines, complemented by research roles at the International Rice Research Institute and Université Catholique de Louvain.